IGC Pharma, Inc. (IGC) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-06 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-06-08 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2026-04-20 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-03-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-12 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-01-06 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-01-02 | 8-K | Charter Amendments | SEC |
| 2025-12-15 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-11-14 | 8-K | Acquisition or Disposition, Financial Statements & Exhibits | SEC |
| 2025-10-14 | 8-K | Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-01 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-06-17 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-27 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-08-27 | 8-K | Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-02 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2024-04-05 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-28 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-22 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-03-13 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.